A Clinical Trial for Evaluating the Efficacy of Magnesium in Migraine Prophylaxis

Document Type : Original Article


1 Department of Neurology, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran

2 Department of Neurology, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran.

3 Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran.


Background and Objective: Migraine is a common, episodic, and disabling disorder. Preventive therapy is used to reduce the frequency, duration, and severity of attacks. This study was done to asseses the effect of  oral magnesium supplementation and propranolol on patients with moderate to severe migraine.
Subjects and Methods: This is a double-blinded, placebo controlled, randomized study of 110 subjects allocated into two groups (55 patients in each). The case group received propranolol 20 mg/bid and magnesium oxide 500 mg/d and the control group received propranolol 20 mg/bid and placebo). Number of migraine attacks  in month ( frequency), headache severity and Migraine Disability Assessment Test (MIDAS) were assessed 1 month and 3 month after the initiation of drug treatment protocol. Gathered data were analyzed with SPSS 21 software,  with pResults: Statistically significant reduction in number of migraine attacks, headache severity and MIDAS score were obtained after third month in both groups. Magnesium produced significant reduction of headache severity (3.89±0.72 Vs 4.62±0.95, P=0.0001), but no significant difference in the number of migraine attacks were recorded between both groups.
Conclusion: According to this study, the combination of magnesium with propranolol  is more effective in reducing the severity of migraine headache than propranolol alone.  It seems that oral magnesium supplement specially in severe migraine can be useful for add on to the first line migraine prophylaxis drugs.


-Ropper  AH, Brown RH. Adams and victor's principles of neurology. 8th ed. New york: Mc Graw Hill, Medical Pub; 2005 . p144-54.
2-Raskin NH, Green MG. Headache. In: Rowland Lp, Editor. Merritts Neurology. 11th ed . Philadelphia; Lippincott Williams and Wilkins; 2005. P. 46-8.
3- Christopher J. Boes, David J. Capobianco, F. Michael Cutrer, David W. Dodick, Ivan Garza, Jerry W. Swanson. Headache and other Cranio Facial Pain. Neurology in clinical practice the neurogical discover. 4th ed. Philadelphia; Butter Worth–Heinemann; 2004. P. 2055-103.
4-Headache Classification Comitee of the International Diagnostic Criteria of the Headache Disorder. Cranial neuralgias and central causes of facial pain;1(supp1):1-96.
5-Shuu-Jiun Wang, Ping-Kun Chen, Jong-Ling , Comorbidities in Migraine. Front Neurol. 2010; 1: 16. Published  online 2010 August 23.
 6-Linde K, Rossnagel K. Propranolol for migraine prophylaxis. Cochrane Database Syst Rev 2004;(2):CD003225.
7-Bartolini M, Silvestrini M, Taffi R, Lanciotti C, Luconi R, Capecci M, et al. Efficacy of topiramate and valproate in chronic migraine. Clin NeuroPharmacol 2005;28(6):277-9.
8-Mauskop A. Evidence linking magnesium deficiency to migraines. Cephalalgia 1999;19(9):766-7.
9-Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 1996;16(4):257-63.
10-Pfaffenrath V, Wessely P, Meyer  C, Isler HR, Evers S, Grotemeyer KH, et al. Magnesium in the prophylaxis of migraine--a double-blind placebo-controlled study. Cephalalgia 1996;16(6):436-40.
11-Wang F, Van Den Eeden SK, Ackerson LM, Salk SE, Reince RH, Elin RJ. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache 2003;43(6):601-10.
12-Köseoglu E, Talaslioglu A, Gönül AS, Kula  M. The effects of magnesium prophylaxis in migraine without aura. Magnes Res 2008;21(2):101-8.
13-Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G. Magnesium prophylaxis of  menstrual  migraine: effects on intracellular magnesium. Headache 1991;31(5):298-301.
14-Mauskop A, Altura BM. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci 1998;5(1):24-7.
15-Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004;291(8):965-73.
16-Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development  and  testing of  the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology 2001;56(6 Suppl 1):s20–8.
A Cl